“…Additionally, patients with AMEAS can also display anomalies at the central nervous system (CNS), craniofacial region, vertebras, and ribs, and on cardiovascular system [Arroyo et al, ]. Currently 23 patients with AMEAS have been reported [Schenk et al, ; Sassani and Yanoff, ; Rogers, ; Arroyo et al, ; Sandler et al, ; Ulman et al, ; Shah et al, ; Imaizumi et al, ; Menetrey et al, ; Messina et al, ; Bonneau et al, ; Petrackova et al, ; Bardakjian and Schneider, ; Hill et al, ; Morini et al, ; Kelberman et al, ; Williamson et al, ; Zenteno et al, ; Bakrania et al, ; Chassaing et al, ]. The heterozygous loss of function in the coding region of SRY (sex determining region Y)‐box 2 gene ( SOX2 ) has been previously identified in 10–15% of patients with bilateral AO/MO [Williamson et al, ].…”